| Literature DB >> 26879347 |
Tadesse Eguale1, Ephrem Engidawork2, Wondwossen A Gebreyes3, Daniel Asrat4, Haile Alemayehu5, Girmay Medhin6, Roger P Johnson7, John S Gunn8.
Abstract
BACKGROUND: Salmonellae are major worldwide zoonotic pathogens infecting a wide range of vertebrate species including humans. Consumption of contaminated dairy products and contact with dairy cattle represent a common source of non-typhoidal Salmonella infection in humans. Despite a large number of small-scale dairy farms in Addis Ababa and its surrounding districts, little is known about the status of Salmonella in these farms.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26879347 PMCID: PMC4754838 DOI: 10.1186/s12866-016-0638-2
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Locations of Addis Ababa and surrounding districts where fecal samples from dairy cattle were collected (source: Original Ethiopian shape file was obtained from Ethiopian Mapping Agency)
Animal level prevalence of Salmonella and its unadjusted association with selected characteristics
| Characteristics | Categories | Number | Weighted apercent positive for |
|
|---|---|---|---|---|
| Sex | Male | 101 | 1.4 | 0.483 |
| Female | 1102 | 2.4 | ||
| Age | <6 month | 280 | 4.5 | 0.023 |
| 6 months–2 years | 162 | 0.0 | ||
| 2 years–5 years | 143 | 2.9 | ||
| 5 years–8 years | 496 | 1.6 | ||
| ≥8 years | 122 | 2.5 | ||
| Study site | Sebeta | 141 | 2.0 | <0.001 |
| Addis Ababa | 319 | 4.2 | ||
| Adaa | 184 | 5.0 | ||
| Barake | 151 | 0.4 | ||
| Welmera | 195 | 0.0 | ||
| Sululta | 213 | 0.2 | ||
| Herd Size | Small [5–20) | 480 | 1.8 | 0.117 |
| Medium [20–50) | 369 | 2.1 | ||
| Large [50+ | 354 | 4.3 | ||
| Have diarrhoea | No | 1169 | 2.1 | 0.012 |
| Yes | 34 | 9.4 | ||
| Overall | 1203 | 2.3 |
aThe result was weighted by the probability of selecting animals from its respective farm
Herd level prevalence of Salmonella and its unadjusted association with selected farm level characteristics
| Characteristics | Categories | Number of farms studied | Percent positive for |
|
|---|---|---|---|---|
| Study site | Sebeta | 20 | 5.0 | 0.372 |
| Addis Ababa | 38 | 13.2 | ||
| Adaa | 12 | 16.7 | ||
| Barake | 19 | 5.3 | ||
| Welmera | 18 | 0.0 | ||
| Sululta | 25 | 4.0 | ||
| Herd Size | Small [5–20) | 79 | 3.8 | 0.047 |
| Medium [20–50) | 33 | 9.1 | ||
| Large [50+ | 20 | 20.0 | ||
| Farm diarrhoea status | Diarrheic | 24 | 25.0 | <0.001 |
| Non-diarrheic | 108 | 3.7 | ||
| Overall | 132 | 7.6 |
Salmonella serotype distribution and number and percent of intermediate and resistant isolates to antimicrobial agents
| Serotype | Number | No. of intermediately resistant and resistant isolates | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amp | Amc | Cf | Cip | Gm | K | Tmp | Te | Su | S | Nitro | Na | N | |||||||||||||||
| I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | I | R | ||
| Aberdeen | 1 | – | – | – | – | – | – | 1 | – | – | – | 1 | – | – | – | 1 | – | 1 | – | 1 | – | – | 1 | 1 | – | 1 | – |
| Dublin | 3 | – | – | – | 2 | – | – | – | – | – | – | – | – | – | – | – | 1 | – | 3 | – | – | – | – | – | – | – | |
| I:6,7,14:–:I,w | 1 | – | 1 | – | 1 | – | 1 | 1 | – | – | – | – | – | – | – | 1 | – | – | – | 1 | – | – | 1 | 1 | – | – | – |
| Kentucky | 5 | – | 5 | 2 | 3 | – | 5 | – | 5 | – | 5 | 4 | – | – | 1 | – | 5 | – | 5 | – | 5 | 4 | 1 | – | 5 | – | 2 |
| LivingstoneVar.14+ | 1 | – | – | – | – | – | – | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1 | – | – |
| Mikawasima | 1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1 | – | – | 1 | – | – | – | – | – | |
| Saintpaul | 6 | 1 | – | – | – | 1 | – | – | – | – | – | 4 | – | – | – | 4 | – | 3 | 2 | 5 | 1 | 2 | 3 | – | – | 3 | – |
| Typhimurium | 7 | – | – | – | 2 | – | – | – | – | – | 3 | – | – | – | 4 | – | 3 | – | 7 | – | 1 | 1 | 1 | – | 1 | – | |
| Virchow | 5 | – | 3 | 3 | – | – | 3 | 1 | – | 1 | 1 | 1 | – | – | – | – | 1 | 1 | 1 | 1 | 2 | 1 | 3 | – | 2 | – | – |
| Total | 30 | 1 | 9 | 5 | 4 | 5 | 9 | 4 | 5 | 1 | 6 | 13 | – | – | – | 10 | 6 | 10 | 8 | 18 | 8 | 9 | 10 | 3 | 8 | 5 | 2 |
| % R | 3.3 | 30 | 16. 7 | 13.3 | 16. 7 | 30 | 13.3 | 16.7 | 3.3 | 20 | 43.3 | – | – | 3.3 | 33.3 | 20 | 33.3 | 26.7 | 60 | 26.7 | 30 | 33.3 | 10 | 26.7 | 16.7 | 6.7 | |
| % (I + R) | 33.3 | 30 | 46.7 | 30 | 23.3 | 43.3 | 3.3 | 53.3 | 60 | 86.7 | 63.3 | 36.7 | 23.3 | ||||||||||||||
Since all isolates were susceptible to Amikacin, Chloramphenicol, Cefoxitin, Ceftriaxone and Sulfamethoxazole + Trimethoprim, they were not included in the table
Amp Ampicillin, Amc Amoxicillin and clavulanic acid, Cf Cephalothin, Cip Ciprofloxacin, Gm Gentamicin, K Kanamycin, Tmp Trimethoprim, Te Tetracycline, Su Sulfisoxazole, S Streptomycin, Nitro Nitrofurantoin, Na Nalidixic acid, N Neomycin, I Intermediate, R Resistant
Salmonella serotypes isolated from dairy cattle in various study sites and their antimicrobial resistance pattern
| Number | Study site | Farm Code | Serotype | R-pattern | |
|---|---|---|---|---|---|
| Intermediate | Resistant | ||||
| 1 | Adaa | DZC −03 | Aberdeen | CipKTeSuSNaN | NitroS |
| 2 | Adaa | DZC −03 | Saintpaul | NitroSuS | – |
| 3 | Adaa | DZC −03 | Saintpaul | TeSuS | Nitro |
| 4 | Adaa | DZC −03 | Saintpaul | AmpCfKTeSNaN | SuNitro |
| 5 | Adaa | DZC −03 | Saintpaul | KTeN | SuSNitro |
| 6 | Adaa | DZC −03 | Saintpaul | KS |
|
| 7 | Adaa | DZC −03 | Saintpaul | NitroKTeSuSN | |
| 8 | Adaa | DZC-06 | Typhimurium var. copehagen PT 193 | CfKS |
|
| 9 | Adaa | DZC-06 | Typhimurium var. copehagen PT 193 | CfTeSuS |
|
| 10 | Adaa | DZC-06 | Typhimurium var. copehagen PT U285 | KTeSuSNitroNaN |
|
| 11 | Adaa | DZC-06 | Typhimurium var. copehagen PT193 | TeS |
|
| 12 | Addis Ababa | AAC-25 | I:6,7,14:-:I,w | CipTeSNa | AmpAmcCfNitro |
| 13 | Addis Ababa | AAC-38 | Kentucky | KNitro | AmpAmcCfCipGmTeSuSNa |
| 14 | Addis Ababa | AAC-25 | Kentucky | Nitro | AmpAmcCfCipGmTeSuSNa |
| 15 | Addis Ababa | AAC-38 | Kentucky | KNitro | AmpAmcCfCipGmTeSuSNa |
| 16 | Addis Ababa | AAC-38 | Kentucky | AmcKNitro | AmpCfCipGmTeSuSNaN |
| 17 | Addis Ababa | AAC-38 | Kentucky | AmcK | AmpCfCipGmTmpTeSuSNitroNaN |
| 18 | Addis Ababa | AAC-25 | Livingstone Var.14+ | Cip | Na |
| 19 | Addis Ababa | AAC-09 | Mikawasima | SuNitro |
|
| 20 | Addis Ababa | AAC-23 | Virchow | Amc | AmpCf |
| 21 | Addis Ababa | AAC-23 | Virchow | AmcK | AmpCfCipGmTeSuSNitroNa |
| 22 | Addis Ababa | AAC-23 | Virchow | AmcSu | AmpCfSNitroNa |
| 23 | Addis Ababa | AAC-23 | Virchow | GmSNitro |
|
| 24 | Addis Ababa | AAC-24 | Virchow | – | Nitro |
| 25 | Barake | BAR- 18 | Typhimurium PT Atypical | KSuS | Nitro |
| 26 | Barake | BAR- 18 | Typhimurium PT 67 | S |
|
| 27 | Sebeta | SC-04 | Dublin | Cf,S |
|
| 28 | Sebeta | SC-04 | Dublin | CfSuS |
|
| 29 | Sebeta | SC-04 | Dublin | S | – |
| 30 | Sululta | Suc-07 | Typhimurium var. copehagen PT Atypical | TeS |
|
PT Phagetype, Amp Ampicillin, Amc Amoxicillin and clavulanic acid, Cf Cephalothin, Cip Ciprofloxacin, Gm Gentamicin, K Kanamycin, Tmp Trimethoprim, Te Tetracycline, Su Sulfisoxazole, S Streptomycin, Nitro Nitrofurantoin, Na Nalidixic acid, N Neomycin